젤리 보충제 시장 규모, 점유율, 성장 및 세계 업계 분석 : 유형 및 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of gummy supplements Market

The global gummy supplements market was valued at USD 11.75 billion in 2025 and is projected to grow to USD 13.23 billion in 2026, reaching USD 35.56 billion by 2034, registering a strong CAGR of 13.16% during 2026-2034. In 2025, North America dominated the market with a 44.32% share, driven by increasing demand for easy-to-consume supplements and strong product innovation.

Gummy supplements are chewable dietary formulations containing vitamins, minerals, probiotics, omega-3 fatty acids, collagen, and other functional ingredients. Designed to resemble confectionery in taste and texture, these supplements offer improved convenience, palatability, and portability compared to traditional pills or capsules. Rising consumer preference for preventive healthcare and convenient nutrition solutions is significantly supporting market growth.

Market Overview and Growth Drivers

Rising Health Awareness and Preventive Care

The growing focus on immunity, energy enhancement, and overall wellness is accelerating demand for dietary supplements. More than one-third of consumers globally use vitamin supplements to maintain energy levels and address micronutrient deficiencies. Busy lifestyles, poor dietary habits, and increased processed food consumption have further amplified the need for convenient supplementation options. Gummies provide a simple and enjoyable alternative, particularly for individuals experiencing "pill fatigue."

Surge in Sports Nutrition Applications

The expanding sports and fitness industry is a key trend shaping the market. Athletes and fitness enthusiasts are increasingly adopting gummy-based supplements for pre-workout, intra-workout, and post-workout nutrition. These products offer minerals, vitamins, and herbal extracts in portable "grab-and-go" formats. The shift toward performance-oriented nutrition and faster recovery solutions is fueling innovation in this segment.

Growing Popularity of CBD Gummies

The legalization of hemp-derived products in several regions has encouraged companies to introduce CBD-infused gummies targeting inflammation relief, digestive health, and stress management. Rising consumer interest in holistic wellness is expected to further boost this category over the forecast period.

Restraining Factors

Despite strong growth prospects, the market faces challenges related to complex manufacturing processes and high sugar content. Water-soluble vitamins such as Vitamin C and B-complex are highly sensitive to heat, light, and moisture, making formulation stability difficult. Additionally, excessive sugar or sugar alcohol content in gummies raises health concerns, particularly among diabetic or weight-conscious consumers. These factors may slightly hinder market expansion.

Market Segmentation Analysis

By Type

The market is segmented into single vitamin, multivitamin, minerals, probiotics, omega-3 fatty acids, collagen, and others.

The single vitamin segment dominated with a 37.94% share in 2026, primarily due to widespread micronutrient deficiencies, especially Vitamins C, D, and B. Indoor lifestyles and limited sun exposure have increased Vitamin D deficiency, supporting demand for targeted supplementation.

By End-User

Based on end-user, the market includes adults, children, and geriatric populations.

The adults segment led the market with a 72.64% share in 2026, driven by convenience, taste appeal, and increasing supplement consumption. Adults aged 18-60 increasingly rely on supplementation to address nutritional gaps caused by hectic schedules. The children segment is also witnessing notable growth due to attractive packaging and parental awareness.

By Distribution Channel

The distribution channels include supermarkets/hypermarkets, pharmacies/drug stores, specialty stores, online retail, and others.

Supermarkets/hypermarkets held the largest share of 47.71% in 2026, attributed to easy accessibility, wide product variety, bulk purchasing options, and competitive pricing. Pharmacies rank second due to professional guidance from pharmacists.

Regional Insights

North America

North America led the global market in 2025, valued at USD 5.21 billion, accounting for 44.32% of total revenue. The U.S. remains the largest contributor, supported by high supplement consumption and product innovation. The U.S. market is projected to grow significantly through 2034, reflecting rising preventive healthcare spending.

Europe

Europe is the second-largest market, driven by strong regulatory frameworks and increasing awareness of immunity and weight management. Countries such as Germany and the U.K. are experiencing rising demand for functional gummies targeting stress relief and metabolic health.

Asia Pacific

Asia Pacific is the fastest-growing region, supported by an expanding aging population, sports nutrition trends, and rising disposable income. China, Japan, and India are witnessing growing interest in beauty-enhancing and immunity-focused gummies.

South America & Middle East & Africa

These regions are gradually expanding due to increasing health awareness and sports nutrition demand, though growth remains moderate compared to developed markets.

Competitive Landscape

Key players in the gummy supplements market include Church & Dwight, Haleon Plc., Nordic Naturals, Hero Nutritionals, Nutri Bears, Jamieson Vitamins, The Clorox Company, H&H Group, Unilever Plc., and Nestle Health Science. Companies are focusing on product diversification, innovative flavors, personalized nutrition, and expansion into pediatric and geriatric segments to strengthen their market presence.

Conclusion

The global gummy supplements market is poised for substantial expansion from USD 11.75 billion in 2025 to USD 35.56 billion by 2034, supported by rising preventive healthcare awareness, sports nutrition adoption, and innovative functional offerings. While manufacturing complexities and sugar-related concerns present challenges, continuous product innovation, CBD integration, and expanding consumer acceptance will sustain long-term growth. With North America leading and Asia Pacific emerging rapidly, the market is expected to witness dynamic development throughout the forecast period (2026-2034).

Segmentation By Type

• Single Vitamin
• Multi Vitamin
• Minerals
• Probiotics
• Omega-3 Fatty Acids
• Collagen
• Others

By End-User

• Adults
• Children
• Geriatric

By Distribution Channel

• Supermarkets/Hypermarkets
• Pharmacies/Drug Stores
• Specialty Stores
• Online Retail
• Others

By Geography

• North America (By Type, End-User, Distribution Channel and Country)
  • U.S. (By End-User)
  • Canada (By End-User)
  • Mexico (By End-User)
• Europe (By Type, End-User Distribution Channel and Country)
  • Germany (By End-User)
  • U.K. (By End-User)
  • Spain (By End-User)
  • Italy (By End-User)
  • France (By End-User)
  • Rest of Europe (By End-User)
• Asia Pacific (By Type, End-User, Distribution Channel, and Country)
  • China (By End-User)
  • India (By End-User)
  • Japan (By End-User)
  • Australia (By End-User)
  • Rest of Asia Pacific (By End-User)
• South America (By Type, End-User, Distribution Channel and Country)
  • Brazil (By End-User)
  • Argentina (By End-User)
  • Rest of South America (By End-User)
• Middle East & Africa (By Type, End-User, Distribution Channel and Country)
  • UAE (By End-User)
  • Saudi Arabia (By End-User)
  • Rest of Middle East & Africa (By End-User)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Market Overview of Related/Parent Market
• 4.2. Industry SWOT Analysis
• 4.3. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches
• 4.4. Supply Chain/Value Chain Analysis
• 4.5. Market Analysis and Insights (in Relation with COVID-19)
  • 4.5.1. Impact of COVID-19 on the Market
  • 4.5.2. Supply Chain Challenges due to the Pandemic
  • 4.5.3. Potential Opportunities Due to COVID-19

5. Global Gummy Supplements Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Size Estimates and Forecast
  • 5.2.1. By Type (Value)
    • 5.2.1.1. Single Vitamin
    • 5.2.1.2. Multi-Vitamin
    • 5.2.1.3. Minerals
    • 5.2.1.4. Probiotics
    • 5.2.1.5. Omega-3 Fatty Acids
    • 5.2.1.6. Collagen
    • 5.2.1.7. Others
  • 5.2.2. By End-User (Value)
    • 5.2.2.1. Adults
    • 5.2.2.2. Children
    • 5.2.2.3. Geriatric
  • 5.2.3. By Distribution Channel (Value)
    • 5.2.3.1. Supermarkets/Hypermarkets
    • 5.2.3.2. Pharmacies/Drug Stores
    • 5.2.3.3. Specialty Stores
    • 5.2.3.4. Online Retail
    • 5.2.3.5. Others
  • 5.2.4. By Region (Value)
    • 5.2.4.1. North America
    • 5.2.4.2. Europe
    • 5.2.4.3. Asia Pacific
    • 5.2.4.4. South America
    • 5.2.4.5. Middle East and Africa

6. North America Gummy Supplements Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Size Estimates and Forecast
  • 6.2.1. By Type (Value)
    • 6.2.1.1. Single Vitamin
    • 6.2.1.2. Multi-Vitamin
    • 6.2.1.3. Minerals
    • 6.2.1.4. Probiotics
    • 6.2.1.5. Omega-3 Fatty Acids
    • 6.2.1.6. Collagen
    • 6.2.1.7. Others
  • 6.2.2. By End-User (Value)
    • 6.2.2.1. Adults
    • 6.2.2.2. Children
    • 6.2.2.3. Geriatric
  • 6.2.3. By Distribution Channel (Value)
    • 6.2.3.1. Supermarkets/Hypermarkets
    • 6.2.3.2. Pharmacies/Drug Stores
    • 6.2.3.3. Specialty Stores
    • 6.2.3.4. Online Retail
    • 6.2.3.5. Others
  • 6.2.4. By Country
    • 6.2.4.1. U.S. (By End-User)
      • 6.2.4.1.1. Adults
      • 6.2.4.1.2. Children
      • 6.2.4.1.3. Geriatric
    • 6.2.4.2. Canada (By End-User)
      • 6.2.4.2.1. Adults
      • 6.2.4.2.2. Children
      • 6.2.4.2.3. Geriatric
    • 6.2.4.3. Mexico(By End-User)
      • 6.2.4.3.1. Adults
      • 6.2.4.3.2. Children
      • 6.2.4.3.3. Geriatric

7. Europe Gummy Supplements Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Size Estimates and Forecast
  • 7.2.1. By Type (Value)
    • 7.2.1.1. Single Vitamin
    • 7.2.1.2. Multi-Vitamin
    • 7.2.1.3. Minerals
    • 7.2.1.4. Probiotics
    • 7.2.1.5. Omega-3 Fatty Acids
    • 7.2.1.6. Collagen
    • 7.2.1.7. Others
  • 7.2.2. By End-User (Value)
    • 7.2.2.1. Adults
    • 7.2.2.2. Children
    • 7.2.2.3. Geriatric
  • 7.2.3. By Distribution Channel (Value)
    • 7.2.3.1. Supermarkets/Hypermarkets
    • 7.2.3.2. Pharmacies/Drug Stores
    • 7.2.3.3. Specialty Stores
    • 7.2.3.4. Online Retail
    • 7.2.3.5. Others
  • 7.2.4. By Country
    • 7.2.4.1. Germany (By End-User)
      • 7.2.4.1.1. Adults
      • 7.2.4.1.2. Children
      • 7.2.4.1.3. Geriatric
    • 7.2.4.2. France(By End-User)
      • 7.2.4.2.1. Adults
      • 7.2.4.2.2. Children
      • 7.2.4.2.3. Geriatric
    • 7.2.4.3. Spain (By End-User)
      • 7.2.4.3.1. Adults
      • 7.2.4.3.2. Children
      • 7.2.4.3.3. Geriatric
    • 7.2.4.4. Italy (By End-User)
      • 7.2.4.4.1. Adults
      • 7.2.4.4.2. Children
      • 7.2.4.4.3. Geriatric
    • 7.2.4.5. U.K. (By End-User)
      • 7.2.4.5.1. Adults
      • 7.2.4.5.2. Children
      • 7.2.4.5.3. Geriatric
    • 7.2.4.6. Rest of Europe (By End-User)
      • 7.2.4.6.1. Adults
      • 7.2.4.6.2. Children
      • 7.2.4.6.3. Geriatric

8. Asia Pacific Gummy Supplements Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
  • 8.1.1. By Type (Value)
    • 8.1.1.1. Single Vitamin
    • 8.1.1.2. Multi-Vitamin
    • 8.1.1.3. Minerals
    • 8.1.1.4. Probiotics
    • 8.1.1.5. Omega-3 Fatty Acids
    • 8.1.1.6. Collagen
    • 8.1.1.7. Others
  • 8.1.2. By End-User (Value)
    • 8.1.2.1. Adults
    • 8.1.2.2. Children
    • 8.1.2.3. Geriatric
  • 8.1.3. By Distribution Channel (Value)
    • 8.1.3.1. Supermarkets/Hypermarkets
    • 8.1.3.2. Pharmacies/Drug Stores
    • 8.1.3.3. Specialty Stores
    • 8.1.3.4. Online Retail
    • 8.1.3.5. Others
  • 8.1.4. By Country
    • 8.1.4.1. China (By End-User)
      • 8.1.4.1.1. Adults
      • 8.1.4.1.2. Children
      • 8.1.4.1.3. Geriatric
    • 8.1.4.2. India (By End-User)
      • 8.1.4.2.1. Adults
      • 8.1.4.2.2. Children
      • 8.1.4.2.3. Geriatric
    • 8.1.4.3. Japan (By End-User)
      • 8.1.4.3.1. Adults
      • 8.1.4.3.2. Children
      • 8.1.4.3.3. Geriatric
    • 8.1.4.4. Australia (By End-User)
      • 8.1.4.4.1. Adults
      • 8.1.4.4.2. Children
      • 8.1.4.4.3. Geriatric
    • 8.1.4.5. Rest of Asia Pacific (By End-User)
      • 8.1.4.5.1. Adults
      • 8.1.4.5.2. Children
      • 8.1.4.5.3. Geriatric

9. South America Gummy Supplements Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
  • 9.1.1. By Type (Value)
    • 9.1.1.1. Single Vitamin
    • 9.1.1.2. Multi-Vitamin
    • 9.1.1.3. Minerals
    • 9.1.1.4. Probiotics
    • 9.1.1.5. Omega-3 Fatty Acids
    • 9.1.1.6. Collagen
    • 9.1.1.7. Others
  • 9.1.2. By End-User (Value)
    • 9.1.2.1. Adults
    • 9.1.2.2. Children
    • 9.1.2.3. Geriatric
  • 9.1.3. By Distribution Channel (Value)
    • 9.1.3.1. Supermarkets/Hypermarkets
    • 9.1.3.2. Pharmacies/Drug Stores
    • 9.1.3.3. Specialty Stores
    • 9.1.3.4. Online Retail
    • 9.1.3.5. Others
  • 9.1.4. By Country
    • 9.1.4.1. Brazil (By End-User)
      • 9.1.4.1.1. Adults
      • 9.1.4.1.2. Children
      • 9.1.4.1.3. Geriatric
    • 9.1.4.2. Argentina (By End-User)
      • 9.1.4.2.1. Adults
      • 9.1.4.2.2. Children
      • 9.1.4.2.3. Geriatric
    • 9.1.4.3. Rest of South America (By End-User)
      • 9.1.4.3.1. Adults
      • 9.1.4.3.2. Children
      • 9.1.4.3.3. Geriatric

10. Middle East and Africa Gummy Supplements Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
  • 10.1.1. By Type (Value)
    • 10.1.1.1. Single Vitamin
    • 10.1.1.2. Multi-Vitamin
    • 10.1.1.3. Minerals
    • 10.1.1.4. Probiotics
    • 10.1.1.5. Omega-3 Fatty Acids
    • 10.1.1.6. Collagen
    • 10.1.1.7. Others
  • 10.1.2. By End-User (Value)
    • 10.1.2.1. Adults
    • 10.1.2.2. Children
    • 10.1.2.3. Geriatric
  • 10.1.3. By Distribution Channel (Value)
    • 10.1.3.1. Supermarkets/Hypermarkets
    • 10.1.3.2. Pharmacies/Drug Stores
    • 10.1.3.3. Specialty Stores
    • 10.1.3.4. Online Retail
    • 10.1.3.5. Others
  • 10.1.4. By Country
    • 10.1.4.1. UAE (By End-User)
      • 10.1.4.1.1. Adults
      • 10.1.4.1.2. Children
      • 10.1.4.1.3. Geriatric
    • 10.1.4.2. Saudi Arabia (By End-User)
      • 10.1.4.2.1. Adults
      • 10.1.4.2.2. Children
      • 10.1.4.2.3. Geriatric
    • 10.1.4.3. Rest of MEA (By End-User)
      • 10.1.4.3.1. Adults
      • 10.1.4.3.2. Children
      • 10.1.4.3.3. Geriatric

11. Competitive Matrix

• 11.1. Business Strategies Adopted by Leading Players
• 11.2. Global Gummy Supplements Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

• 12.1. Church & Dwight
  • 12.1.1. Overview
  • 12.1.2. Description
  • 12.1.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.1.4. Recent Developments
• 12.2. Haleon Plc.
  • 12.2.1. Overview
  • 12.2.2. Description
  • 12.2.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.2.4. Recent Developments
• 12.3. Nordic Naturals
  • 12.3.1. Overview
  • 12.3.2. Description
  • 12.3.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.3.4. Recent Developments
• 12.4. Hero Nutritionals
  • 12.4.1. Overview
  • 12.4.2. Description
  • 12.4.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.4.4. Recent Developments
• 12.5. Nutri Bears
  • 12.5.1. Overview
  • 12.5.2. Description
  • 12.5.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.5.4. Recent Developments
• 12.6. Jamieson Vitamins
  • 12.6.1. Overview
  • 12.6.2. Description
  • 12.6.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.6.4. Recent Developments
• 12.7. The Clorox Company
  • 12.7.1. Overview
  • 12.7.2. Description
  • 12.7.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.7.4. Recent Developments
• 12.8. H&H Group
  • 12.8.1. Overview
  • 12.8.2. Description
  • 12.8.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.8.4. Recent Developments
• 12.9. Unilever Plc.
  • 12.9.1. Overview
  • 12.9.2. Description
  • 12.9.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.9.4. Recent Developments
• 12.10. Nestle Health Science
  • 12.10.1. Overview
  • 12.10.2. Description
  • 12.10.3. Financials (Data as available in public domain and/or on paid databases)
  • 12.10.4. Recent Developments

13. Strategic Recommendations

14. Appendix